Eric Radzimski

He is a qualified Industrial Property Attorney and accredited mediator with over 20 years of experience specialising in patent litigation and the management, protection, and enforcement of patent, trademark, and design portfolios. He is regularly instructed by law firms in complex IP disputes, including patent infringement and invalidity proceedings, seizure actions, and litigation before the Unified Patent Court and national courts.

Since 2019, he has been Partner and President of Cabinet Aubenard (Dijon, Strasbourg, Lyon), combining contentious IP practice with strategic IP advisory work. His previous roles include Head of Biotechnology at Hirsch & Associés (Paris), Director of Intellectual Property at Vivasanté (Laboratoires URGO), where he managed a substantial global portfolio (approximately 600 patents and 3,000 trademarks), Director of Intellectual Property at Novasep (chemical synthesis and industrial chromatography), Head of Industrial Property at Genoplante (plant genomics and GMOs), and Patent Engineer at Institut Pasteur (human biology, including HIV and HPV technologies).

His technical expertise spans pharmaceuticals, generics, biotechnology, organic and industrial chemistry, medical devices, plant genomics, and human biology. It also includes artificial intelligence and data technologies in medical technology, agriculture and plant breeding (including experience with Genoplante Valor), energy technologies and renewable energy, materials science, diagnostics, and cosmetics. He has extensive experience in European and unitary patent litigation, freedom-to-operate analyses, and alternative dispute resolution.

In addition to his technical expertise in intellectual property, he has developed a strong strategic dimension in business-related matters, essential for the valuation and protection of intangible assets in industrial and commercial environments. In his leadership and advisory roles, particularly as Partner and President of Cabinet Aubenard, he advises companies on the development and implementation of comprehensive intellectual property strategies aligned with their commercial and economic objectives.

This includes identifying key assets to be protected, optimising the management of patent, trademark, and design portfolios, and establishing tailored policies to maximise the economic value of innovation.

In his previous positions, he has led complex IP strategies encompassing the evaluation and prioritisation of R&D investments based on their potential value and expected return, the implementation of measures to secure know-how and trade secrets, and the proactive management of infringement risks through close coordination with legal and commercial teams. He has also supported negotiations relating to partnerships, licences, collaborations, and confidentiality agreements, ensuring both strategic and financial outcomes while safeguarding clients’ interests.

He has extensive experience in leading multidisciplinary teams and coordinating with technical, legal, and financial experts to ensure an integrated approach to IP-related business challenges. His strategic approach aims to position intellectual property as a key driver of competitiveness, differentiation, and growth, ensuring alignment between innovation, legal protection, and business objectives.